RANDOMIZED CONTROLLED CLINICAL TRIAL OF EFFICACY OF PASHANBHEDADI GHANVATI IN THE MANAGEMENT OF VAATASHTHILA W.S.R. TO BENIGN PROSTATE HYPERPLASIA

Preeti Bhalke0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Patients having prostate size 30 to 100 gram
•Patients having post void residual volume 50 to 200 ml
•Patients willing to participate in study
•Patients having mild 1 to 7 moderate 8 to 19 international prostate symptom score
•Patients with severe 20 to 35 international prostate symptom score with no other consequences of benign prostate Hyperplasia and reluctant for surgery

•Patients of malignant prostatic enlargement or prostatitis or uremia septicemia or renal failure
•Patients having other urological pathologies like nephrotic syndrome or glomerulo nephritis or chronic kidney diseases etc
•Increased serum creatinine and blood urea
•Patients having HIV or HBsAg or major systemic disorders like uncontrolled HTN or DM or PTB etc
•Patients participating in other clinical trials
•Patients having hematuria
•Patients with acute urine retention which needs surgical intervention
•Patients currently using any other form of medicle therapy for benign prostate hyperplasia

发起方

Preeti Bhalke